Catalyst Wire Dossier Catalyst Wire Dossier

Autologous CSPG4-targeted CAR-T cells

CSPG4-directed CAR-T cells · UNC Lineberger Comprehensive Cancer Center
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous CSPG4-targeted CAR-T cells, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC [Phase 1, Phase 2]

See pricing